Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Paul Maroni

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
39
2024
986
3.720
 Why?
Prostatectomy
8
2019
94
1.440
 Why?
Testicular Neoplasms
7
2023
111
1.070
 Why?
Urology
3
2020
63
0.810
 Why?
Embolism
1
2021
49
0.660
 Why?
Urethra
1
2021
56
0.660
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
76
0.660
 Why?
Androgen Antagonists
4
2024
91
0.650
 Why?
Laser Therapy
1
2021
146
0.590
 Why?
Kidney Medulla
2
2005
31
0.440
 Why?
Clinical Trials as Topic
1
2020
1072
0.440
 Why?
Early Detection of Cancer
5
2023
506
0.380
 Why?
Neoadjuvant Therapy
2
2021
474
0.340
 Why?
Urination Disorders
1
2011
15
0.340
 Why?
Prostate-Specific Antigen
8
2020
162
0.340
 Why?
Male
56
2024
73950
0.320
 Why?
Prostate
7
2023
160
0.320
 Why?
Oxalates
2
2008
11
0.300
 Why?
Neoplasm Grading
5
2021
313
0.270
 Why?
Randomized Controlled Trials as Topic
2
2014
1776
0.260
 Why?
Adenocarcinoma
3
2022
928
0.250
 Why?
Radiotherapy, Adjuvant
2
2018
222
0.250
 Why?
Humans
59
2024
147293
0.240
 Why?
Neoplasm Staging
7
2021
1492
0.230
 Why?
Kidney Tubules, Collecting
1
2005
27
0.230
 Why?
Oxalic Acid
1
2004
4
0.220
 Why?
Brachytherapy
2
2016
133
0.210
 Why?
Urinary Bladder Neoplasms
2
2021
261
0.200
 Why?
Clinical Competence
1
2012
1260
0.200
 Why?
Androgens
4
2024
181
0.190
 Why?
Paraganglioma
1
2022
65
0.170
 Why?
Cell Hypoxia
2
2015
249
0.170
 Why?
Adrenal Gland Neoplasms
1
2022
99
0.170
 Why?
Prolactin
3
1997
88
0.160
 Why?
Cation Transport Proteins
1
2022
120
0.160
 Why?
Adaptor Proteins, Vesicular Transport
2
1997
46
0.160
 Why?
Surveys and Questionnaires
3
2017
6164
0.160
 Why?
Orchiectomy
3
2016
72
0.160
 Why?
Magnetic Resonance Imaging, Interventional
1
2020
30
0.160
 Why?
Aged
21
2021
26514
0.150
 Why?
Risk Assessment
4
2020
3784
0.150
 Why?
Salvage Therapy
2
2018
166
0.150
 Why?
Middle Aged
20
2021
36821
0.150
 Why?
Proanthocyanidins
1
2019
6
0.150
 Why?
Biflavonoids
1
2019
6
0.150
 Why?
Stromal Cells
1
2019
123
0.140
 Why?
Grape Seed Extract
1
2019
29
0.140
 Why?
Anthocyanins
1
2019
28
0.140
 Why?
Catechin
1
2019
23
0.140
 Why?
Euterpe
1
2018
4
0.140
 Why?
Hospitals
2
2023
740
0.140
 Why?
Nomograms
1
2019
59
0.140
 Why?
Digital Rectal Examination
1
2018
10
0.140
 Why?
Reagent Kits, Diagnostic
1
2018
33
0.130
 Why?
Antineoplastic Agents, Phytogenic
1
2019
178
0.130
 Why?
Adaptor Proteins, Signal Transducing
2
1997
430
0.130
 Why?
Mitogen-Activated Protein Kinase Kinases
1
1997
126
0.130
 Why?
Neoplasm Recurrence, Local
2
2018
1166
0.130
 Why?
Urinary Tract Infections
1
2019
212
0.130
 Why?
Biopsy, Needle
2
2016
186
0.130
 Why?
Proton Therapy
1
2017
16
0.130
 Why?
Seminoma
1
2017
20
0.120
 Why?
Surgical Wound Infection
2
2019
334
0.120
 Why?
Plant Extracts
1
2018
191
0.120
 Why?
Sertoli-Leydig Cell Tumor
1
2016
8
0.120
 Why?
Neoplasm Metastasis
5
2019
695
0.120
 Why?
Radiology
1
2019
176
0.120
 Why?
Spectrum Analysis
1
2016
85
0.120
 Why?
Liver
4
1997
1916
0.120
 Why?
Sex Cord-Gonadal Stromal Tumors
1
2015
5
0.120
 Why?
Medical Oncology
1
2019
344
0.110
 Why?
Radiotherapy, Conformal
1
2015
75
0.110
 Why?
Prognosis
7
2019
4383
0.110
 Why?
Proto-Oncogene Proteins
2
1997
627
0.110
 Why?
Risk
2
2015
927
0.110
 Why?
Lymphatic Metastasis
3
2014
338
0.110
 Why?
Neoplastic Stem Cells
1
2019
409
0.110
 Why?
HSP70 Heat-Shock Proteins
2
2008
76
0.110
 Why?
Biopsy
4
2023
1093
0.100
 Why?
Fluorodeoxyglucose F18
1
2015
165
0.100
 Why?
Genomics
1
2019
839
0.100
 Why?
Leydig Cell Tumor
1
2014
8
0.100
 Why?
Cause of Death
1
2016
475
0.100
 Why?
Priapism
1
2013
10
0.100
 Why?
Receptors, Adrenergic, alpha
1
2013
19
0.100
 Why?
Hypertension
1
2022
1280
0.100
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.100
 Why?
Optics and Photonics
1
2014
38
0.100
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.100
 Why?
Spectrometry, Fluorescence
1
2014
166
0.100
 Why?
Proline
1
2013
82
0.100
 Why?
Triglycerides
1
2015
529
0.090
 Why?
Extracellular Vesicles
1
2015
175
0.090
 Why?
Matrix Metalloproteinase 9
2
2010
133
0.090
 Why?
Treatment Outcome
7
2018
11947
0.090
 Why?
Neoplasm Invasiveness
4
2016
512
0.090
 Why?
Drug Interactions
1
2013
405
0.090
 Why?
Telephone
1
2013
177
0.090
 Why?
Cardiovascular Diseases
1
2024
2218
0.090
 Why?
Cell Line
3
2008
2832
0.080
 Why?
Urothelium
1
2011
33
0.080
 Why?
Signal Transduction
4
2004
5272
0.080
 Why?
Survival Rate
4
2017
2110
0.080
 Why?
Lymph Nodes
1
2014
514
0.080
 Why?
Prostatic Hyperplasia
1
2011
41
0.080
 Why?
Mitogen-Activated Protein Kinase 1
4
2008
172
0.080
 Why?
Neoplastic Cells, Circulating
1
2011
81
0.080
 Why?
Spinal Fractures
1
2011
81
0.080
 Why?
Attitude of Health Personnel
1
2019
1220
0.080
 Why?
Proto-Oncogene Proteins c-ets
1
2010
56
0.080
 Why?
Epithelial Cells
2
2008
1141
0.080
 Why?
Combined Modality Therapy
2
2016
1281
0.080
 Why?
Carcinogenesis
2
2022
230
0.080
 Why?
Oxygen
1
2015
998
0.080
 Why?
Survival Analysis
2
2016
1386
0.080
 Why?
Glucose
1
2015
1051
0.080
 Why?
Mitogen-Activated Protein Kinase 3
3
2008
136
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
2
2009
264
0.080
 Why?
Counseling
1
2013
407
0.070
 Why?
Aged, 80 and over
6
2020
8430
0.070
 Why?
Carcinoma
1
2011
231
0.070
 Why?
Decision Making
1
2017
994
0.070
 Why?
Lymph Node Excision
2
2014
173
0.070
 Why?
Survivors
1
2013
528
0.070
 Why?
Lymphatic Diseases
1
2009
21
0.070
 Why?
Postoperative Complications
2
2019
3022
0.070
 Why?
Cystitis
1
2009
24
0.070
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2008
35
0.070
 Why?
Age Factors
4
2017
3372
0.070
 Why?
Logistic Models
3
2019
2142
0.070
 Why?
Neoplasms, Hormone-Dependent
1
2008
33
0.070
 Why?
Patient Education as Topic
1
2013
781
0.070
 Why?
Patient Selection
2
2018
746
0.070
 Why?
Proportional Hazards Models
3
2016
1344
0.060
 Why?
Databases, Factual
3
2019
1504
0.060
 Why?
Cell Line, Tumor
5
2015
3565
0.060
 Why?
Kidney Tubules, Proximal
1
2008
129
0.060
 Why?
Image-Guided Biopsy
2
2020
41
0.060
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1997
165
0.060
 Why?
Societies, Medical
1
2011
914
0.060
 Why?
Diagnostic Imaging
2
2022
342
0.060
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2009
300
0.060
 Why?
Time Factors
4
2014
7173
0.060
 Why?
Chemotherapy, Adjuvant
1
2008
429
0.060
 Why?
Antineoplastic Agents, Hormonal
1
2008
196
0.060
 Why?
Radiotherapy Dosage
2
2018
289
0.060
 Why?
Adult
12
2020
41405
0.060
 Why?
Reactive Oxygen Species
2
2009
616
0.060
 Why?
Animals
11
2022
38410
0.060
 Why?
Follow-Up Studies
4
2016
5476
0.060
 Why?
Oxidative Stress
2
2010
1368
0.060
 Why?
Isoflavones
1
2005
25
0.060
 Why?
Ear, Inner
1
2005
51
0.060
 Why?
Support Vector Machine
2
2016
34
0.060
 Why?
Young Adult
6
2020
14437
0.060
 Why?
Mitotic Index
2
2015
25
0.050
 Why?
History, 21st Century
1
2006
227
0.050
 Why?
Body Fluids
1
2005
71
0.050
 Why?
Cell Count
1
2005
321
0.050
 Why?
Mice
4
2022
18491
0.050
 Why?
Urinary Incontinence
1
2005
65
0.050
 Why?
MAP Kinase Signaling System
2
2008
308
0.050
 Why?
Growth
1
2004
49
0.050
 Why?
Kidney Neoplasms
1
2009
421
0.050
 Why?
Informed Consent
1
2006
200
0.050
 Why?
Disease Progression
2
2018
2890
0.050
 Why?
Propensity Score
2
2016
379
0.050
 Why?
Cell Proliferation
3
2019
2529
0.050
 Why?
Receptors, Nicotinic
1
2005
328
0.050
 Why?
Protein-Tyrosine Kinases
2
1997
432
0.050
 Why?
Multivariate Analysis
2
2017
1550
0.050
 Why?
United States
5
2019
16313
0.050
 Why?
Mass Screening
2
2015
1375
0.050
 Why?
Kaplan-Meier Estimate
2
2016
975
0.050
 Why?
Transcriptional Regulator ERG
1
2022
14
0.050
 Why?
Urinary Bladder
1
2004
198
0.040
 Why?
Antineoplastic Agents
1
2013
2231
0.040
 Why?
Sensitivity and Specificity
3
2016
2017
0.040
 Why?
Rats, Wistar
3
1997
450
0.040
 Why?
Rats
6
2005
5613
0.040
 Why?
Cell Survival
2
2019
1111
0.040
 Why?
Serine Endopeptidases
1
2022
130
0.040
 Why?
Intestines
1
2004
356
0.040
 Why?
Src Homology 2 Domain-Containing, Transforming Protein 1
2
1997
10
0.040
 Why?
Shc Signaling Adaptor Proteins
2
1997
10
0.040
 Why?
Testosterone
2
2015
417
0.040
 Why?
Hyperthermia, Induced
1
2001
120
0.040
 Why?
Gene Expression Regulation, Enzymologic
1
2001
269
0.040
 Why?
Oncogene Proteins, Fusion
1
2022
212
0.040
 Why?
Biomarkers, Tumor
2
2020
1339
0.040
 Why?
Fever
1
2001
320
0.040
 Why?
Mitogen-Activated Protein Kinases
2
2001
288
0.040
 Why?
Adolescent
5
2022
22825
0.040
 Why?
Cerebellum
1
2001
227
0.040
 Why?
Cell Transformation, Neoplastic
1
2022
340
0.040
 Why?
Reperfusion
2
1996
54
0.040
 Why?
Jagged-1 Protein
1
2019
22
0.040
 Why?
Feeding Behavior
1
2005
693
0.040
 Why?
Geography
1
2019
187
0.040
 Why?
Inflammation
1
2010
2920
0.040
 Why?
Receptor, Notch1
1
2019
63
0.040
 Why?
Zinc
1
2022
309
0.030
 Why?
Retrospective Studies
4
2023
17560
0.030
 Why?
Fruit and Vegetable Juices
1
2018
23
0.030
 Why?
Stress, Physiological
1
2001
445
0.030
 Why?
Tissue Kallikreins
1
2018
2
0.030
 Why?
Enzyme Activation
4
2008
762
0.030
 Why?
Radiometry
1
2018
56
0.030
 Why?
Kallikreins
1
2018
26
0.030
 Why?
Spheroids, Cellular
1
2019
82
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2019
122
0.030
 Why?
Enzyme Induction
1
1997
88
0.030
 Why?
Janus Kinase 2
1
1997
31
0.030
 Why?
Carrier Proteins
1
2022
731
0.030
 Why?
Cells, Cultured
1
2005
4169
0.030
 Why?
MAP Kinase Kinase 1
1
1997
70
0.030
 Why?
Quality of Life
2
2013
3246
0.030
 Why?
Tumor Cells, Cultured
1
2019
891
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2018
143
0.030
 Why?
Health Care Surveys
1
2019
538
0.030
 Why?
National Cancer Institute (U.S.)
1
2017
55
0.030
 Why?
Phosphorylation
4
2008
1721
0.030
 Why?
Phenotype
3
2010
3216
0.030
 Why?
Protein Kinase C
2
1994
251
0.030
 Why?
Ultrasonography
1
2020
795
0.030
 Why?
Prospective Studies
2
2020
8164
0.030
 Why?
Feminization
1
2015
6
0.030
 Why?
Epoxy Compounds
1
2015
31
0.030
 Why?
Carnitine O-Palmitoyltransferase
1
2015
49
0.030
 Why?
Altitude
1
2019
470
0.030
 Why?
Heterografts
1
2015
143
0.030
 Why?
Environmental Exposure
1
2019
583
0.030
 Why?
T-Lymphocytes, Helper-Inducer
1
1995
132
0.030
 Why?
Ischemia
2
1996
424
0.030
 Why?
Proteins
2
1997
1024
0.030
 Why?
Disease-Free Survival
1
2016
779
0.030
 Why?
Cell Movement
1
2019
966
0.030
 Why?
Female
7
2021
80076
0.030
 Why?
Colorado
2
2015
4591
0.030
 Why?
Immunohistochemistry
2
2010
1730
0.030
 Why?
Least-Squares Analysis
1
2014
73
0.030
 Why?
Mice, Nude
1
2015
680
0.020
 Why?
Positron-Emission Tomography
1
2015
344
0.020
 Why?
Needles
1
2014
63
0.020
 Why?
Risk Factors
2
2019
11017
0.020
 Why?
SEER Program
1
2014
232
0.020
 Why?
Radiotherapy
1
2014
210
0.020
 Why?
T-Lymphocyte Subsets
1
1995
421
0.020
 Why?
Cytochrome P-450 CYP3A
1
2013
93
0.020
 Why?
Estrogens
1
2015
368
0.020
 Why?
Aging
3
2010
1992
0.020
 Why?
Equipment Design
1
2014
527
0.020
 Why?
T-Lymphocytes, Regulatory
1
1995
415
0.020
 Why?
Child
3
2022
22979
0.020
 Why?
Oxidation-Reduction
1
2015
1077
0.020
 Why?
Lipid Metabolism
1
2015
538
0.020
 Why?
Population Surveillance
1
2014
486
0.020
 Why?
Reoperation
1
2014
644
0.020
 Why?
Cell Separation
1
2011
306
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2011
330
0.020
 Why?
Life Style
1
2013
504
0.020
 Why?
Apoptosis
1
2019
2454
0.020
 Why?
Atrophy
1
2010
201
0.020
 Why?
Microscopy, Fluorescence
1
2011
409
0.020
 Why?
Anxiety
1
2017
1149
0.020
 Why?
DNA Primers
1
2010
505
0.020
 Why?
Nephrolithiasis
1
2009
10
0.020
 Why?
JNK Mitogen-Activated Protein Kinases
2
2001
153
0.020
 Why?
Prostatitis
1
2009
17
0.020
 Why?
Cohort Studies
1
2020
6099
0.020
 Why?
Metaplasia
1
2009
57
0.020
 Why?
Tumor Stem Cell Assay
1
2008
34
0.020
 Why?
Imaging, Three-Dimensional
1
2012
587
0.020
 Why?
Social Support
1
2013
655
0.020
 Why?
Anoikis
1
2008
31
0.020
 Why?
Incidence
1
2015
2954
0.020
 Why?
Socioeconomic Factors
1
2013
1342
0.020
 Why?
NADPH Oxidases
1
2009
123
0.020
 Why?
Feasibility Studies
1
2013
1147
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
980
0.020
 Why?
Immunoblotting
2
2001
296
0.020
 Why?
Genes, Immediate-Early
1
2008
26
0.020
 Why?
Proto-Oncogene Proteins c-jun
1
2008
54
0.020
 Why?
Tyrosine
2
2001
218
0.020
 Why?
Blotting, Western
1
2010
1186
0.020
 Why?
Receptors, Androgen
1
2009
149
0.020
 Why?
Gonadal Steroid Hormones
1
2009
143
0.020
 Why?
Practice Patterns, Physicians'
1
2017
1379
0.020
 Why?
DNA, Mitochondrial
1
2009
212
0.020
 Why?
Adaptation, Psychological
1
2013
736
0.020
 Why?
Magnetic Resonance Imaging
1
2020
3980
0.020
 Why?
Pilot Projects
1
2013
1912
0.020
 Why?
Glutathione
1
2009
370
0.020
 Why?
RNA, Messenger
2
2008
2812
0.020
 Why?
Base Sequence
1
2010
2175
0.020
 Why?
Proto-Oncogene Proteins c-myc
1
2008
169
0.010
 Why?
RNA, Small Interfering
1
2008
643
0.010
 Why?
Models, Animal
1
2008
394
0.010
 Why?
Phosphotyrosine
2
1996
38
0.010
 Why?
Chinchilla
1
2005
35
0.010
 Why?
Equol
1
2005
5
0.010
 Why?
Guinea Pigs
1
2005
159
0.010
 Why?
Hypoglycemic Agents
1
2015
1415
0.010
 Why?
Antioxidants
1
2009
550
0.010
 Why?
Swine
1
2008
828
0.010
 Why?
Bladder Exstrophy
1
2004
18
0.010
 Why?
Acid-Base Equilibrium
1
2004
23
0.010
 Why?
Meat
1
2005
64
0.010
 Why?
Bicarbonates
1
2004
45
0.010
 Why?
Stress, Psychological
1
2013
1174
0.010
 Why?
Diagnosis, Differential
1
2009
1518
0.010
 Why?
Biomarkers
1
2015
4351
0.010
 Why?
Meningomyelocele
1
2004
63
0.010
 Why?
Infant, Newborn
1
2015
6543
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2791
0.010
 Why?
Body Height
1
2004
205
0.010
 Why?
Hypoxia
1
2010
1208
0.010
 Why?
Referral and Consultation
1
2009
886
0.010
 Why?
Receptor, IGF Type 1
1
2001
64
0.010
 Why?
Infant
1
2015
10194
0.010
 Why?
Bone Density
1
2004
493
0.010
 Why?
Child, Preschool
1
2015
12016
0.010
 Why?
Animals, Newborn
1
2001
914
0.010
 Why?
Gene Expression Regulation
1
2008
2625
0.010
 Why?
ErbB Receptors
1
2001
638
0.010
 Why?
Mutation
1
2009
4130
0.010
 Why?
Neoplasms
1
2013
2946
0.010
 Why?
GRB2 Adaptor Protein
1
1996
12
0.010
 Why?
Proto-Oncogene Proteins c-raf
1
1996
46
0.010
 Why?
Sialoglycoproteins
1
1996
157
0.010
 Why?
Neurons
1
2005
1672
0.010
 Why?
Receptors, Interleukin-1
1
1996
211
0.010
 Why?
Rats, Sprague-Dawley
1
2001
2542
0.010
 Why?
Interleukin 1 Receptor Antagonist Protein
1
1996
253
0.010
 Why?
Lymphocyte Count
1
1995
165
0.010
 Why?
Phosphotransferases
1
1994
26
0.010
 Why?
Precipitin Tests
1
1994
90
0.010
 Why?
Densitometry
1
1994
36
0.010
 Why?
CD4 Lymphocyte Count
1
1995
282
0.010
 Why?
Injections, Intraperitoneal
1
1994
116
0.010
 Why?
Ornithine Decarboxylase
1
1994
13
0.010
 Why?
Molecular Weight
1
1994
313
0.010
 Why?
Genes, myc
1
1994
51
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1994
332
0.010
 Why?
Cytosol
1
1994
213
0.010
 Why?
Substrate Specificity
1
1994
387
0.010
 Why?
Kinetics
1
1996
1569
0.010
 Why?
Interleukin-1
1
1996
961
0.010
 Why?
Gene Expression
1
1994
1481
0.000
 Why?
Antibodies, Monoclonal
1
1994
1514
0.000
 Why?
T-Lymphocytes
1
1995
2017
0.000
 Why?
Maroni's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)